EFFECTS OF OBSTRUCTIVE SLEEP APNEA & TREATMENT ON PERSISTENT ASTHMA

阻塞性睡眠呼吸暂停的影响

• 批准号: 7603755
• 负责人: Flavia B Consens
• 金额: $ 0.34万
• 依托单位: UNIVERSITY OF MICHIGAN AT ANN ARBOR
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-03-01 至 2007-09-16
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7603755
• 关键词: Asthma; Blood; Breathing; Chronic; Computer Retrieval of Information on Scientific Projects Database; Condition; Continuous Positive Airway Pressure; Funding; Grant; Health Care Costs; Health Resources; Inflammatory; Institution; Link; Lung; Morbidity - disease rate; Obstructive Sleep Apnea; Patients; Quality of life; Research; Research Personnel; Resources; Sampling; Sleep; Sleep disturbances; Snoring; Societies; Source; Symptoms; United States National Institutes of Health; Week

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Asthma is a common chronic inflammatory lung condition that imposes a growing burden to our society in terms of morbidity, quality of life and healthcare costs. Despite significant progress in our understanding of asthma causes and treatment, some asthmatics have persistent symptoms and have a poor quality of life. Obstructive sleep apnea (stopping breathing while sleeping) is also a common condition. Sleep related complaints are common among asthmatics, but there are no studies to show how frequent obstructive sleep apnea (OSA) is among patients with persistent asthma (PA). The magnitude of improvement in asthma control achieved by treatment of OSA with continuous positive airway pressure (CPAP) is not known either. We propose a study to assess how frequently OSA is found in a sample of patients with PA and frequent sleep related complains suggestive of OSA (such as snoring, witnessed episodes of stopping breathing while asleep and daytime sleepiness), by performing nocturnal sleep studies. We will try to determine the impact of 8-week of continuous positive airway pressure (CPAP) treatment on asthma control, quality of life and health resources utilization. Also, we will evaluate mechanisms that may link sleep disturbances to the onset of asthma symptoms and changes in blood inflammatory markers after 8-week therapy with CPAP.'

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 哮喘是一种常见的慢性炎症性肺部疾病，在发病率、生活质量和医疗费用方面给我们的社会带来了越来越大的负担。尽管我们对哮喘的病因和治疗的了解有了很大的进步，但一些哮喘患者仍然有持续的症状，生活质量很差。阻塞性睡眠呼吸暂停(睡眠时停止呼吸)也是一种常见的情况。与睡眠有关的主诉在哮喘患者中很常见，但没有研究表明阻塞性睡眠呼吸暂停(OSA)在持续性哮喘(PA)患者中的频率。通过持续气道正压(CPAP)治疗OSA对哮喘控制的改善程度也尚不清楚。我们建议进行一项研究，通过进行夜间睡眠研究，评估在PA患者样本中发现OSA的频率，并通过进行夜间睡眠研究，评估与OSA有关的频繁主诉(如打鼾声、入睡时呼吸停止和日间嗜睡的事件)。我们将尝试确定持续8周的持续气道正压(CPAP)治疗对哮喘控制、生活质量和卫生资源利用的影响。此外，我们还将评估睡眠障碍与哮喘症状的发生以及CPAP治疗8周后血液炎症标志物变化之间的联系。